Wikidata

(Q34511975)

English

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

scientific article

In more languages

Statements

title
From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A). (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16603249
retrieved
2 August 2017
publication date
28 February 2006
1 reference
stated in
Europe PubMed Central
PubMed ID
16603249
retrieved
2 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34511975&oldid=1741922322"